Results per Page:
Fred Hutch researchers discover molecular switch that helps prostate cancer quickly change its biology to evade therapy
Drs. Andrew Hsieh and Rashmi Mishra identify a key step in the protein-making process that turns a treatable form of prostate cancer into a more lethal, drug-resistant subtype — and a way to switch it back
Glow-tagging the androgen receptor reveals an unexpected vulnerability in advanced prostate cancer
A recent study by a Fred Hutch prostate cancer expert finds potential new drug targets using an innovative tagging method that can be applied to other hormone-driven cancers